Anthracene Quickview (CASRN 120-12-7)

Status of Data for Anthracene

File First On-Line: 09/01/1990; Last Significant Revision: 01/01/1991

Category (section)	Status	Last Revised
Oral RfD Assessment	On-line	07/01/1993
Inhalation RfC Assessment	No data	09/01/1994
Carcinogenicity Assessment	On-line	01/01/1991

Synonyms

120-12-7 Anthracen [German] Anthracene Anthracin Green Oil

HSDB 702 NSC 7958 Paranaphthalene Tetra Olive N2G

Chronic Health Hazard Assessments for Noncarcinogenic Effects

Reference Dose for Chronic Oral Exposure (RfD)

Critical Effect	Point of Departure*	UF	MF	RfD
No observed effects	NOEL : 1000 mg/kg-day	3000	1	3 x10-1 mg/kg-day

* The Point of Departure listed serves as a basis from which the Oral RfD was derived. See Discussion of Conversion Factors and Assumptions for more details.

• Principal and Supporting Studies (Oral RfD)
  • Subchronic toxicity study in mice, U.S. EPA, 1989
• Confidence in the Oral RfD
  • Study -- Low
  • Database -- Low
  • RfD -- Low

Top of page

---

Reference Concentration for Chronic Inhalation Exposure (RfC)

Not Assessed under the IRIS Program.

Top of page

Carcinogenicity Assessment for Lifetime Exposure

• Weight-of-Evidence Characterization
  • D (Not classifiable as to human carcinogenicity)
• Weight-of-Evidence Narrative:
  • Based on no human data and inadequate data from animal bioassays.
  • This may be a synopsis of the full weight-of-evidence narrative. See IRIS Summary.

---

Quantitative Estimate of Carcinogenic Risk from Oral Exposure

• Not Assessed under the IRIS Program.

---

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure

• Not Assessed under the IRIS Program.